VIEKIRAX Combination Tablets
Showing 1 - 25 of >10,000
Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)
Completed
- Hepatitis C Virus
- (no location specified)
Jul 28, 2021
Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))
Helicobacter Pylori Infection Trial (Lacidophilin tablets in combination with vonorazan dual therapy, Placebo in combination
Not yet recruiting
- Helicobacter Pylori Infection
- Lacidophilin tablets in combination with vonorazan dual therapy
- Placebo in combination with vonorazan dual therapy
- (no location specified)
Feb 18, 2023
Chronic Hepatitis b Trial in Chongqing, Xi'an (Placebo, TQA3605 tablets, Entecavir dispersible tablets)
Recruiting
- Chronic Hepatitis b
- Placebo
- +4 more
-
Chongqing, Chongqing, China
- +2 more
Nov 27, 2023
Hemophilia B Trial in Beijing (Sodium valproate extended-release tablets)
Recruiting
- Hemophilia B
- Sodium valproate extended-release tablets
-
Beijing, ChinaPLA General Hospital
Jun 17, 2023
NSCLC Trial in Shanghai (BL-B01D1, Osimertinib Mesylate Tablets)
Not yet recruiting
- Non-small Cell Lung Cancer
- BL-B01D1
- Osimertinib Mesylate Tablets
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
May 25, 2023
H.Pylori Infection Trial in Beijing (Rifasutenizol capsules, Rabeprazole sodium enteric-coated tablets, Amoxicillin Capsules)
Not yet recruiting
- H.Pylori Infection
- Rifasutenizol capsules
- +7 more
-
Beijing, ChinaPeking University Third Hospital
May 3, 2023
Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed Trial in Hangzhou (dalpiciclib;
Recruiting
- Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed
- dalpiciclib; fluvestrant; compound gossypol acetate tablets
-
Hangzhou, Zhejiang, ChinazhejiangCH
Nov 9, 2023
Orthodontic Pain Trial in Salt Lake City (Acetaminophen/Naproxen Sodium)
Not yet recruiting
- Orthodontic Pain
- Acetaminophen/Naproxen Sodium
-
Salt Lake City, UtahJBR Clinical Research LLP
Apr 25, 2023
Disease Activity When Ubrogepant Tablets Are Combined With
Recruiting
- Migraine
-
Bronx, New YorkMontefiore/Albert Einstein
Jan 9, 2023
Recurrent Glioblastoma Trial in Beijing (ASC40 tablets, Placebo tablets, Bevacizumab)
Recruiting
- Recurrent Glioblastoma
- ASC40 tablets
- +2 more
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital，Capital Medical University
Jun 28, 2022
Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets, SPH4336 Tablets Placebo)
Not yet recruiting
- Locally Advanced or Metastatic Breast Cancer
- SPH4336 Tablets
- SPH4336 Tablets Placebo
-
Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital, Sun Yat-sen University
May 8, 2023
Healthy Trial in Mexico City (A1: Ibuprofen/Acetaminophen Fixed dose combination (Laboratorios Silanes S.A. de C.V.), A2:
Completed
- Healthy
- A1: Ibuprofen/Acetaminophen Fixed dose combination (Laboratorios Silanes S.A. de C.V.)
- +2 more
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Jun 22, 2022
Healthy Volunteer Trial (Lumacaftor 200 mg/Ivacaftor 125 mg Film-Coated Tablet, Lumacaftor 200 mg Film-Coated Tablet
Not yet recruiting
- Healthy Volunteer
- Lumacaftor 200 mg/Ivacaftor 125 mg Film-Coated Tablet
- Lumacaftor 200 mg Film-Coated Tablet Formulation
- (no location specified)
Jul 21, 2023
Advanced Gastrointestinal Tumors Trial in Shanghai (Donafenib Tosilate Tablets, KN046 Injection)
Recruiting
- Advanced Gastrointestinal Tumors
- Donafenib Tosilate Tablets
- KN046 Injection
-
Shanghai, ChinaZhongshan Hospital Affiliated to Fudan University
Nov 28, 2022
Breast Cancer Brain Metastases Trial in Guangzhou (SPH4336 Tablets)
Not yet recruiting
- Breast Cancer Brain Metastases
- SPH4336 Tablets
-
Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital, Sun Yat-sen University
May 24, 2023
Advanced Solid Tumors Trial (SHR-A2009 for injection ; Almonertinib Mesilate Tablets, SHR-A2009 for injection;Adebrelimab
Not yet recruiting
- Advanced Solid Tumors
- SHR-A2009 for injection ； Almonertinib Mesilate Tablets
- SHR-A2009 for injection；Adebrelimab Injection
- (no location specified)
Oct 17, 2023
Healthy Volunteers (Intended Indication: Type 2 Diabetes) Trial in Berlin (Dapagliflozin/sitagliptin FDC, Sitagliptin,
Completed
- Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
- Dapagliflozin/sitagliptin FDC
- +2 more
-
Berlin, GermanyResearch Site
Jun 30, 2022
CTEPH Trial in Durham (Macitentan Tablets, Riociguat, balloon pulmonary angioplasty)
Not yet recruiting
- CTEPH
- Macitentan Tablets
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Jan 24, 2023
Tinea Corporis, Tinea Cruris, Tinea Faciei Trial (Terbinafine Tablets, Itraconazole)
Not yet recruiting
- Tinea Corporis
- +3 more
- Terbinafine Tablets
- Itraconazole
- (no location specified)
May 20, 2023
Solid Tumors, Head Neck Cancer Trial in Shijiazhuang (SYH2051 tablets, Intensity-Modulated Radiation Therapy (IMRT))
Recruiting
- Solid Tumors
- Head and Neck Cancer
- SYH2051 tablets
- Intensity-Modulated Radiation Therapy (IMRT)
-
Shijiazhuang, Hebei, ChinaClinical Trials Information Group
Aug 21, 2023
Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)
Recruiting
- Metastatic Colorectal Cancer
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023
To Determine Bioequivalence Under Fed Conditions Trial (Metformin and Vildagliptin 850/50 mg)
Completed
- To Determine Bioequivalence Under Fed Conditions
- Metformin and Vildagliptin 850/50 mg
- (no location specified)
Apr 16, 2022
HIV-1-infection Trial in Montréal (abacavir, dolutegravir and lamivudine dispersible tablets, Triumeq Dispersible Tablets 5 mg
Completed
- HIV-1-infection
- abacavir, dolutegravir and lamivudine dispersible tablets
- Triumeq Dispersible Tablets 5 mg GSK1349572 [Dolutegravir]/ 60 mg Abacavir/ 30 mg Lamivudine
-
Montréal, Quebec, CanadaAltasciences
Mar 10, 2022